Dextenza, Ocular Therapeutix

Drug device safe, tolerated for post-cataract painA sustained-release dexamethasone implant is safe and well tolerated when used to control pain and inflammation after cataract surgery, according to investigators.
Intracanalicular insert soothes ocular itching in allergic conjunctivitisA phase III study of dexamethasone insert, 0.4 mg (Dextenza, Ocular Therapeutix) found that the sustained-release intracanalicular insert is safe, effective, and well tolerated for treating ocular itching associated with allergic conjunctivitis.
Sustained-release dexamethasone depot effective in lowering fluorescein stainingA dropless option for steroid therapy showed encouraging results in a phase II safety and efficacy study in patients with inflammatory dry eye disease.